STARIMAGIN logo

Star Imaging and Path Lab Ltd

STARIMAGIN·BSE·
₹69.10▼ -8.90 (-11.41%)
Market Cap120.29 Cr
PE Ratio6.25
Volume45,000
Day High - Low78.00 - 62.40
52W High-Low152.00 - 46.00

Star Imaging and Path Lab Ltd (STARIMAGIN): company summary

The company's business is improving, with annual revenue rising 5.4% and annual net profit growing 20.5%.

Star Imaging and Path Lab Ltd (STARIMAGIN) is a micro-cap Healthcare Services company valued at ₹120 crore operating in Healthcare Service Provider on the NSE and BSE.

Recent price move
Star Imaging and Path Lab Ltd last traded at ₹69.1, sharply down 11.41% on the day.
Financial performance
The company's business is improving, with annual revenue rising 5.4% and annual net profit growing 20.5%. However, the latest quarter showed a decline in net profit, falling 10.0% compared to the same quarter a year earlier, despite a 4.9% increase in revenue.
Valuation multiples
The stock trades at 6.3 times earnings, 1.22 times book value.
Things to watch
The company's latest quarter net profit fell 10.0% compared to the same quarter a year earlier. The stock is 48.7% below its 52-week high, and the company's net profit margin, while up, is still lower than its peers in the healthcare sector.
Where it stands
Star Imaging and Path Lab Ltd has shown strong growth in both revenue and net profit over the past year, with a 168.1% profit CAGR over three years. However, the latest quarter's net profit decline highlights a potential challenge in maintaining profitability. The stock is currently 48.7% below its 52-week high.

Summarised by DocStoX's model on 2026-10-18 from company filings, exchange data and news. This is a factual summary, not a rating or a recommendation. Informational only, not investment advice. Consult a SEBI-registered adviser before investing.

DocStoX Score
7.1/10
Strong
Fair Value
Sign in to see
ROE
16.61%
Strong
P/E
6.25x
Cheap
Debt / Equity
0.18
Low
Industry
Healthcare Services
Healthcare Service Provider
Overall View
Mixed

Price performance

Day₹62.40
₹78.00
52W₹46.00
₹152.00
DocStoX take

Supported by valuation (9.0) and growth (8.9), but held back by momentum (1.0). Valuation looks strong at 9.0, but that is offset by momentum at 1.0. We are calling it Mixed rather than resolving the conflict for you.

DocStoX score

Low confidence
7.1
/10
Strong
Quality
Excellent
ROE 16.6%
Valuation
Cheap
P/E 6.3×
Growth
Strong
Revenue +15.1% 3Y CAGR
Risk
Moderate
D/E 0.18
Momentum
Weak
22% of 52-week range

At a glance

Market Cap
₹120 Cr
52W High / Low
₹152 / ₹46
Dividend Yield
0.00%
Promoter Holding
71.92%
EPS (TTM)
₹11.05
Book Value
₹66.65

Key highlights

  • Profit compounding 168% a year
  • Low leverage — D/E 0.18
  • Profitable in all of the last 5 years
  • Momentum is weak (1.0/10)
  • Near the bottom of its 52-week range (22%)
4 Positives3 Watchouts

Growth

Financials

Shareholding

Technicals

Peers

News

Forecasts

About the company

More data

Filings, corporate actions and ownership detail — opened on demand.

More Healthcare Services stocks · Healthcare Service Provider

Star Imaging and Path Lab Ltd peers in Healthcare Services

Other Healthcare Services stocks on the NSE & BSE. See the full Healthcare Services sector list.